P38Β/Mapk11 Deficiency Exacerbates Cardiac Structural And Electrophysiological Remodeling And Contributes To Immune Dysregulation In The Aging Heart
As we get older, our hearts become more vulnerable to various diseases, including heart failure and irregular heartbeats. Scientists have long known that a group of proteins called p38 MAPKs are involved in how the heart changes with age. However, the specific roles of individual p38 proteins in the aging heart have been a mystery.
Recent research focused on one particular p38 protein, p38β, to understand its function. Using mice that lacked p38β, researchers observed significant changes in their aging hearts. These mice developed an enlarged main pumping chamber of the heart (left ventricular hypertrophy), experienced electrical abnormalities that could lead to irregular heartbeats (QT prolongation), and showed problems with how their heart cells handled calcium, which is crucial for proper heart function. They were also more prone to arrhythmias, had increased scarring of heart tissue (myocardial fibrosis), and exhibited an altered inflammatory environment in their hearts.
Further investigation into the genes active in these hearts revealed that without p38β, pathways related to the body’s immediate immune response and protein balance were suppressed, while pathways involved in a more specific, adaptive immune response were promoted.
These findings highlight p38β as a crucial player in maintaining the heart’s structure, electrical stability, and immune system balance during aging. Its absence leads to unfavorable changes in heart structure and increases the risk of dangerous irregular heartbeats. This research suggests that treatments broadly targeting p38 proteins might have unintended negative effects in age-related heart conditions, emphasizing the importance of understanding the specific roles of each p38 protein.
Source: link to paper